Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Claritev Corporation (CTEV : NYSE)

• Company Description    Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK. Number of Employees: 3,000

• Price / Volume Information    Yesterday's Closing Price: $21.67 Daily Weekly Monthly 20 Day Moving Average: 214,365 shares Shares Outstanding: 17.05 (millions) Market Capitalization: $369.43 (millions) Beta: 0.76 52 Week High: $74.00 52 Week Low: $11.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.75% 1.53% 12 Week 52.93% 41.38% Year To Date -49.31% -49.35%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 7900 TYSONS ONE PLACE SUITE 400 - MCLEAN,VA 22102 USA ph: 212-780-2000 fax: - investor@claritev.com http://www.claritev.com

• General Corporate Information    Officers Travis S. Dalton - Chief Executive Officer Douglas M. Garis - Executive Vice President and Chief Financial Offic Brock Albinson - Senior Vice President and Chief Accounting Officer Richard A. Clarke - Director Anthony Colaluca, Jr. - Director Peer Information Claritev Corporation (HLIS) Claritev Corporation (AZTA) Claritev Corporation (APYI) Claritev Corporation (RNVA) Claritev Corporation (HMSY) Claritev Corporation (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 62548M209 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 17.05 Most Recent Split Date: 9.00 (0.03:1) Beta: 0.76 Market Capitalization: $369.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-3.74 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-14.44 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 1.40 Price / Sales: 0.38 EPS Growth vs. Year Ago Period: -28.57% vs. Previous Quarter: 9.63% Sales Growth vs. Year Ago Period: 5.77% vs. Previous Quarter: -0.76% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - -4.36 12/31/25 - -3.96 09/30/25 - -3.96 Current Ratio 03/31/26 - 1.28 12/31/25 - 0.86 09/30/25 - 1.21 Quick Ratio 03/31/26 - 1.28 12/31/25 - 0.86 09/30/25 - 1.21 Operating Margin 03/31/26 - -22.06 12/31/25 - -20.53 09/30/25 - -21.14 Net Margin 03/31/26 - -29.27 12/31/25 - -29.45 09/30/25 - -35.93 Pre-Tax Margin 03/31/26 - -38.41 12/31/25 - -38.64 09/30/25 - -47.56 Book Value 03/31/26 - -13.75 12/31/25 - -10.10 09/30/25 - -6.17 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©